Weight management in a cohort of Irish inpatients with serious mental illness (SMI) using a modular behavioural programme. A preliminary service evaluation

BMC Psychiatry

Volumn 8, Issue , 2008, Pages

  Bushe, Chris J ^a   McNamara, Dermot ^a   Haley, Cliff ^b   McCrossan, Mary Fleming ^c   Devitt, Pat ^d  

^a ELI LILLY AND COMPANY   (United States)

^b LETTERKENNY GENERAL HOSPITAL   (Ireland)

^c Nursing Dept   (Ireland)

^d ADELAIDE AND MEATH HOSPITAL   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

PSYCHOTROPIC AGENT;

ARTICLE; BEHAVIOR THERAPY; BODY WEIGHT; CLINICAL ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEALTH PROGRAM; HOSPITAL PATIENT; HUMAN; INTERVENTION STUDY; IRELAND; MALE; MENTAL DISEASE; MULTICENTER STUDY; OUTPATIENT CARE; SIDE EFFECT; TREATMENT DURATION; TREATMENT RESPONSE; WEIGHT CHANGE; WEIGHT GAIN; WEIGHT REDUCTION; WELLBEING; ACUTE DISEASE; ADULT; HEALTH CARE QUALITY; HOSPITALIZATION; METHODOLOGY; STATISTICS;

ACUTE DISEASE; ADULT; BEHAVIOR THERAPY; BODY WEIGHT; COHORT STUDIES; FEMALE; HOSPITALIZATION; HUMANS; IRELAND; MALE; MENTAL DISORDERS; PROGRAM EVALUATION; SEVERITY OF ILLNESS INDEX;

EID: 52949093198     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-8-76     Document Type: Article

References (27)

1. Osborn DP Levy G Nazareth I Petersen I Islam A King MB: Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom's General Practice Research Database. Arch Gen Psychiatry 2007, 64(2):242-9. Erratum in: Arch Gen Psychiatry. 2007 Jun; 64(6):736. 10.1001/archpsyc.64.2.242 17283292
2. Hennekens CH Hennekens AR Hollar D Casey DE; Schizophrenia and increased risks of cardiovascular disease. Am Heart J 2005, 150(6):1115-21. 10.1016/j.ahj.2005.02.007 16338246
3. Lawrence DM Holman CD Jablensky AV Hobbs MS: Death rate from ischaemic heart disease in Western Australian psychiatric patients 1980-1998. Br J Psychiatry 2003, 182:31-6. 10.1192/bjp.182.1.31 12509315
4. Thakore JH Mann JN Vlahos I Martin A Reznek R: Increased visceral fat distribution in drug-naive and drug-free patients with schizophrenia. Int J Obes Relat Metab Disord 2002, 1:137-41. 10.1038/sj.ijo.0801840 11791159
5. McEvoy J Meyer M Goff D Nasrallah H Davis S Sullivan L: Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III. Schizophr Res 80, 1:19-32. 2005 Dec 1; 10.1016/ j.schres.2005.07.014 16137860
6. Sorensen H Mortensen EL Reinisch JM Mednick JA: Height, weight and body mass index in early adulthood and risk of schizophrenia. Acta Psychiatr Scand 2006, 114:49-54. 10.1111/j.1600-0447.2006.00784.x 16774661
7. McEvoy JP Lieberman JA Perkins DO Hamer RM Gu H Lazarus A Sweitzer D Olexy C Weiden P Strakowski SD: Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: A randomized, double-blind 52-week comparison. Am J Psychiatry 2007, 164(7):1050-60. 10.1176/appi.ajp.164.7.1050 17606657
8. Lambert M Haro JM Novick D Edgell ET Kennedy L Ratcliffe M Naber D: Olanzapine vs. other antipsychotics in actual out-patient settings: Six months tolerability results from the European Schizophrenia Out-patient Health Outcomes study. Acta Psychiatr Scand 2005, 111:232-43. 10.1111/ j.1600-0447.2004.00451.x 15701108
9. Haddad P. Weight change with atypical antipsychotics in the treatment of schizophrenia. Psychopharmacol 2005, 19(6 Suppl):16-27. 10.1177/ 0269881105058378
10. HaroJM Suarez D Novick D Brown J Usall J Naber D: SOHO Study Group Three-year antipsychotic effectiveness in the outpatient care of schizophrenia: Observational versus randomized studies results. Eur Neuropsychopharmacol 2007, 17(4):235-44. 10.1016/j.euroneuro.2006.09.005 17137759
11. Pendlebury J Haddad P Dursun S: Evaluation of a behavioural weight management programme for patients with severe mental illness: 3 year results. Hum Psychopharm Clin Exp 2005, 20:447-448. 10.1002/hup.707
12. Pendlebury J Bushe C Wildgust H Holt R: Long term maintenance of weight loss in patients with severe mental illness through a behavioural programme in UK. Acta Psychiatr Scand 2007, 115:286-294. 10.1111/ j.1600-0447.2006.00906.x 17355519
13. Brar JS Ganguli R Pandina G Turkoz I Berry S Mahmoud R: Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder. J Clin Psychiatry 2005, 66:205-212. 15705006
14. Bushe C Haddad P Peveler R Pendlebury J: The role of lifestyle interventions and weight management in schizophrenia. Journal of Psychopharmacology 2005, 19(suppl):28-35. 10.1177/0269881105058682
15. Bushe C Haley C McNamara D Fleming-McCrossan M Devitt P: Weight management by group interventions. The longer term outcomes at 20 months in an Irish cohort of patients with serious mental illness Poster presented at 25th Biennial Congress of the Collegium Internationale Neuro-Psychopharmacologicum 9-13 July 2006; Chicago, IL.
16. Evans S Newton R Higgins S: Nutritional intervention to prevent weight gain in patients commenced on olanzapine: A randomised controlled trial. Aus and N Zealand Journal of Psychiatry 2005, 39:479-486 10.1111/ j.1440-1614.2005.01607.x
17. Hoffmann V Ahl J Meyers A Schuh L Shults K Collins D Jensen L: Wellness intervention for patients with serious and persistent mental illness. J Clin Psych 2005, 66:1576-1579.
18. Vreeland B Minsky S Menza M Rigassio Radler D Roemheld-Hamm B Stern R: A program for managing weight gain associated with atypical antipsychotics. Psychiatr Serv 2003, 54(8):1155-7. 10.1176/ appi.ps.54.8.1155 12883145
19. Alvarez M Gonzalez-Blanch C Perez-Iglesias R Perez-Pardal T Martinez-Garcia O: Early intervention in antipsychotic-induced weight gain in first episode-psychosis. Schizophr Bull 2005, 21:S518.
20. Ganguli R Brar JS: Prevention of weight gain by behavioural interventions in patients starting novel antipsychotics. Schizophr Bull 2005, 21:S561
21. Lee SJ Choi EJ Kwon JS: A Naturalistic Multicenter Trial of a 12-Week Weight Management Program for Overweight and Obese Patients with Schizophrenia or Schizoaffective Disorder. J Clin Psychiatry 2008. Feb 27
22. Werneke U Taylor D Sanders TA Wessely S; Behavioural management of antipsychotic-induced weight gain: A review. Acta Psychiatr Scand 2003, 108(4):252-9. 10.1034/j.1600-0447.2003.00190.x 12956825
23. Mauri M Simoncini M Castrogiovanni S Iovieno N Cecconi D Dell'Agnello G Quadrigli MRossi A Donda P Fagiolini A Cassano GB: A psychoeducational program for weight loss in patients who have experienced weight gain during antipsychotic treatment with olanzapine. Pharmacopsychiatry 2008, 41(1):17-23. 10.1055/s-2007-992148 18203047
24. Menza M Vreeland B Minsky S Gara M Radler DR Sakowitz M: Managing atypical antipsychotic-associated weight gain: 12-month data on a multimodal weight control program J Clin Psychiatry 2004, 65(4):471-7. 15119908
25. Smith S Yeomans D Bushe CJ Erikkson C Holmes R: A Well-being Programme in Severe Mental Illness. Reducing Risk for Physical Ill-health: A post-programme service evaluation at 2 years. European Psychiatry 2007. 17765483
26. Werneke U Taylor D Sanders TA: Options for pharmacological management of obesity in patients treated with atypical antipsychotics. Int Clin Psychopharmacol 2002, 17(4):145-60. 10.1097/00004850-200207000-00001 12131598
27. Faulkner G Cohn T Remington G: Interventions to reduce weight gain in schizophrenia Cochrane Database of Systematic Reviews 2007:CD005148. DOI: 10.1002/14651858.CD005148.pub2